Nalaganje...
Novel therapeutic targets for pancreatic cancer
Pancreatic cancer has become the fourth leading cause of cancer death in the last two decades. Only 3%-15% of patients diagnosed with pancreatic cancer had 5 year survival rate. Drug resistance, high metastasis, poor prognosis and tumour relapse contributed to the malignancies and difficulties in tr...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4138462/ https://ncbi.nlm.nih.gov/pubmed/25152585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i31.10825 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|